CDSCO

“India is well-positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five…

Reinforcing its commitment to strengthening global manufacturing and quality benchmarks, the Indian Pharmaceutical Alliance (IPA)…

Eli Lilly and Company (India) announced that the Central Drugs Standard Control Organization (CDSCO) has granted…

The Society for Pharmaceutical Dissolution Science (SPDS) conducted a highly interactive value-adding programme on Dissolution…

While India’s CDMOs are well positioned to capitalise on the booming GLP-1 market, the recurring episodes of contaminated cough…

The Central Drugs Standard Control Organization (CDSCO) has issued a clarification concerning the regulatory approval process for…

Mankind Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical…

The pen will be available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing healthcare…

Durvalumab in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Durvalumab as adjuvant…

The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has expressed urgent concerns over the recent circular issued…